TCL Archive Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development. January 13, 2006
TCL Archive In Brief: ‘WSJ” Articles Call Attention To Problems With Cancer Program Knipmeyer to Leave NCI May 19, 1989
TCL Archive In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says February 12, 1999
TCL Archive NCI Advisors Approve New Grant Programs In Systems Genetics, Tumor Stem Cells. November 23, 2007
